Literature DB >> 11426026

Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium.

Y Suzuki1, Y Tsutsumi, M Nakagawa, H Suzuki, K Matsushita, M Beppu, H Aoki, Y Ichikawa, Y Mizushima.   

Abstract

OBJECTIVE: Osteoclasts may be involved in the process of rheumatoid bone destruction. To test this hypothesis, we developed an in vitro model of bone destruction by osteoclast-like cells derived from cultured rheumatoid synovial tissue without using any inducers.
METHODS: Synovial tissues were obtained from rheumatoid arthritis and osteoarthritis patients and tissue pieces of about 2 mm(3) that contained synovial lining were cultured. Multinucleated cells derived from cultured synovial tissues were studied cytochemically and morphologically for osteoclast-specific markers.
RESULTS: Fibroblast-like and macrophage-like cells from the tissue pieces proliferated in the coexistence of lymphocytes. After 14 days of culture, multinucleated cells with tartrate-resistant acid phosphatase activity appeared. These cells expressed vacuolar H(+)-ATPase, the vitronectin receptor and cathepsin K. Although binding of (125)I-labelled salmon calcitonin was very low, the cells contained ringed structures of F-actin and showed strong bone-resorbing activity on ivory slices. Proliferation of macrophage-like cells and formation of multinucleated cells continued during 6 months of culture in the presence of fibroblast-like cells. The bone-resorbing activity of multinucleated cells derived from rheumatoid synovial tissue was much higher than that of cells from osteoarthritis synovial tissue, and was related to the disease activity of rheumatoid arthritis.
CONCLUSION: Our culture system reproduced in vitro the process of bone destruction by rheumatoid synovium, including the proliferation and fusion of precursor cells, polarization, activation and bone tissue resorption. This system may provide a tool for understanding the mechanisms of bone destruction in rheumatoid arthritis and for the development of new therapies to prevent bone destruction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426026     DOI: 10.1093/rheumatology/40.6.673

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  Bone destruction in arthritis.

Authors:  E M Gravallese
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 2.  Pathogenesis of bone lesions in rheumatoid arthritis.

Authors:  Steven R Goldring; Ellen M Gravallese
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

3.  Paeoniflorin ameliorates collagen-induced arthritis via suppressing nuclear factor-κB signalling pathway in osteoclast differentiation.

Authors:  Haiyan Xu; Li Cai; Lili Zhang; Guojue Wang; Rongli Xie; Yongshuai Jiang; Yuanyang Yuan; Hong Nie
Journal:  Immunology       Date:  2018-02-17       Impact factor: 7.397

4.  Regulation of bone lysis in inflammatory diseases.

Authors:  David R Haynes; Tania N Crotti
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

5.  Umbelliferone Ameliorates Complete Freund Adjuvant-Induced Arthritis via Reduction of NF-κB Signaling Pathway in Osteoclast Differentiation.

Authors:  Guofeng Wu; Wenbo Nie; Qiu Wang; Youguo Hao; Shaohua Gong; Yuxin Zheng; Hao Lv
Journal:  Inflammation       Date:  2021-01-23       Impact factor: 4.092

6.  Elucidation of Potential Targets of San-Miao-San in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Man Chu; Ting Gao; Xu Zhang; Wulin Kang; Yu Feng; Zhe Cai; Ping Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-18       Impact factor: 2.629

7.  Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritis.

Authors:  Anne Sofie Sørensen; Morten Nørgaard Andersen; Kristian Juul-Madsen; Amalie Dyrelund Broksø; Cæcilie Skejø; Henrik Schmidt; Thomas Vorup-Jensen; Tue Wenzel Kragstrup
Journal:  Arthritis Res Ther       Date:  2022-02-14       Impact factor: 5.156

8.  Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approach.

Authors:  Zhiwei Ji; Dan Wu; Weiling Zhao; Huiming Peng; Shengjie Zhao; Deshuang Huang; Xiaobo Zhou
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

9.  OsteoRheumatology: a new discipline?

Authors:  Marta Favero; Andrea Giusti; Piet Geusens; Steven R Goldring; Willem Lems; Georg Schett; Gerolamo Bianchi
Journal:  RMD Open       Date:  2015-08-15

10.  The study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA mice.

Authors:  Yanqing Gu; Weimin Fan; Guoyong Yin
Journal:  Mediators Inflamm       Date:  2014-08-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.